Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Ebola: Democratic Republic of Congo (CRS Report for Congress)

Premium   Purchase PDF for $24.95 (3 pages)
add to cart or subscribe for unlimited access
Release Date Revised Oct. 4, 2018
Report Number IN10917
Report Type Insight
Authors Tiaji Salaam-Blyther
Source Agency Congressional Research Service
Older Revisions
  • Premium   Revised Aug. 3, 2018 (3 pages, $24.95) add
  • Premium   Revised July 25, 2018 (3 pages, $24.95) add
  • Premium   Revised July 5, 2018 (3 pages, $24.95) add
  • Premium   Revised June 12, 2018 (3 pages, $24.95) add
  • Premium   June 2, 2018 (3 pages, $24.95) add
Summary:

On July 24, 2018, the World Health Organization (WHO) reported that an outbreak in the Democratic Republic of Congo (DRC) had ended after having infected 54 people, 33 of whom died. The outbreak began on May 8, 2018, when DRC health officials reported to WHO that two Ebola cases had been detected in the Equateur province, a rural area in the northwestern portion of the country. The disease later spread to Mbandaka, a city that holds 1.2 million people and serves as a regional trade hub. This was the ninth Ebola outbreak in DRC since the disease was discovered in 1976, when an outbreak infected 318 people and killed 280 (Figure 1). In contrast to the 2014-2016 West Africa Ebola outbreak, the WHO response was swift. On the same day that the outbreak was reported, WHO released $2 million from its Contingency Fund for Emergencies (CFE), deployed a team to the region, and activated an emergency incident management system. WHO also issued a $57 million appeal to control the outbreak. The international community exceeded the request, having provided $63 million. The largest contributions were provided by Germany (€5 million), United Kingdom (£5 million), and the United States ($5.3 million). Other types of support included in-kind contributions for medical evacuations and intercountry air transport from Norway and the European Union, respectively; technical assistance from Germany, Guinea, the United Kingdom, and the United States; and the provision of vaccines to protect over 3,300 people.